“ After so many years of globalization, it is clear that we are interdependent and interconnected. Cutting off the channels of cooperation would lead to harm on… ”
In Conversation
“ Our dedication to advancing technology and making tangible differences in healthcare is unwavering. Partnering with Jacobio Pharmaceuticals offers a unique opportunity to collaborate on groundbreaking initiatives… ”
“ Our aim is not to become as large as the IQVIAs or Parexels of this world, but to remain a mid-sized CRO that is as global… ”
“ We want to be the prime example of an innovative, science-driven biotech from China, showcasing the best of world capability in terms of innovation, rather than… ”
“ Our intention is to become a China-based international company that leads in the genomics space globally ”
“ BioDuro has very strong capabilities on the discovery side and has a significant presence in both China and the US. Meanwhile, Sundia is extremely strong in… ”
“ The traditional bulk analysis method is well-established and suited for diseases that are more homogenous, but cancer and some types of autoimmune diseases are well-known for… ”
“ Despite the fact that I joined the company during the peak of the COVID-19 epidemic in China, we have achieved a number of milestones in the… ”
“ We believe, to make a meaningful impact on treatment, it is necessary to have more than one drug or regimen. We therefore see combination therapies as… ”
“ Unmet medical needs in eye care are huge in the Asia markets, and biotech companies will become increasingly important players and innovation drivers in this area ”
“ Fundamentally, we are convinced that the China ophthalmology market is still a relatively blank slate with huge potential for innovative therapies and drugs, compared to the… ”
“ By now, we have a platform of over 500 billion small molecules, and in terms of published numbers, we probably have the largest DEL collections in… ”
